Top Markets
Coin of the day
Sunmax Biotechnology Co., Ltd. Sunmax Biotechnology Co., Ltd.

Sunmax Biotechnology Co., Ltd.

4728
Rangering i aksjer #11505
Established in Tainan City, Taiwan, in 2001, Sunmax Biotechnology Co., Ltd.... Established in Tainan City, Taiwan, in 2001, Sunmax Biotechnology Co., Ltd. functions as a biomedical enterprise. The company specializes in the development, manufacturing, and commercialization of collagen-based medical devices across Taiwan and mainland China. Its diverse product line encompasses Porcogen, a sterile, purified collagen solution valuable for medical device applications, tissue engineering, and research. Sunmax also supplies various dermal fillers, including the Sunmax collagen implant series (I-Plus, I) and FACIALGAIN collagen implants (with and without lidocaine), engineered for correcting facial aesthetic concerns such as wrinkles. For dental procedures, they provide specialized collagen-based solutions like Sunmax collagen dental bone grafts, membranes, and granules, used for augmenting or reconstructing the alveolar ridge, extraction sockets, and in periodontics. Additionally, the Sunmax collagen bone graft matrix serves as a bone void filler that naturally resorbs and facilitates new bone formation during recovery. The company's offerings extend to skincare products, such as Sunmax 12 jiao didi spray, Sunmax 11 collagen moisturizing cream, and a general collagen skincare line, all designed for post-dermal filler treatment aftercare.
Aksjekurs
$12.72
Sist synkronisert: 2026-08-27
Markedsverdi
$692.75M
Endring (1 dag)
0.00%
Endring (1 år)
-4.67%
Land
TW
Handel Sunmax Biotechnology Co., Ltd. (4728)

Kategori

P/B-forhold for Sunmax Biotechnology Co., Ltd. (4728)
P/B-forhold per 2026 TTM: 0
Ifølge Sunmax Biotechnology Co., Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Sunmax Biotechnology Co., Ltd. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
3.7087 -
US
- -
CH